|
ZNF192 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.78169998146893E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47020173812962E-11 |
| Normal-vs-Stage2 |
1.09230000000515E-06 |
| Normal-vs-Stage3 |
7.27779947418128E-10 |
| Normal-vs-Stage4 |
9.17339981754139E-10 |
| Stage1-vs-Stage2 |
9.335400E-01 |
| Stage1-vs-Stage3 |
1.123790E-01 |
| Stage1-vs-Stage4 |
1.050610E-01 |
| Stage2-vs-Stage3 |
3.047600E-01 |
| Stage2-vs-Stage4 |
2.009000E-01 |
| Stage3-vs-Stage4 |
6.862800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.55730001011523E-09 |
| Normal-vs-AfricanAmerican |
3.121100E-03 |
| Normal-vs-Asian |
1.62770000033952E-07 |
| Caucasian-vs-AfricanAmerican |
1.573180E-01 |
| Caucasian-vs-Asian |
9.345400E-01 |
| AfricanAmerican-vs-Asian |
2.081600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.35330002759559E-09 |
| Normal-vs-Female |
6.35889996214445E-09 |
| Male-vs-Female |
3.142200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.99949953763701E-10 |
| Normal-vs-Age(41-60Yrs) |
1.94539939712968E-11 |
| Normal-vs-Age(61-80Yrs) |
9.93919946346011E-10 |
| Normal-vs-Age(81-100Yrs) |
1.478520E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.995200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.396410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.501000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.758800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.851000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.731000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.977000E-03 |
| Classical-VS-Follicular |
1.109150E-01 |
| Classical-VS-Other |
2.055600E-01 |
| Classical-VS-Normal |
8.7412999949521E-08 |
| Tall-VS-Follicular |
1.985190E-01 |
| Tall-VS-Other |
8.814200E-01 |
| Tall-VS-Normal |
2.4200996762147E-10 |
| Follicular-VS-Other |
5.233400E-01 |
| Follicular-VS-Normal |
1.78699999242582E-09 |
| Other-VS-Normal |
1.996070E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.53792559085286E-12 |
| Normal-vs-N1 |
1.93430000017258E-07 |
| N0-vs-N1 |
9.173400E-01 |
|
|
